This trial is evaluating whether Treatment will improve 1 primary outcome and 11 secondary outcomes in patients with Atherogenesis. Measurement will happen over the course of Baseline, week 6, 12, and 14 on trial.
This trial requires 30 total participants across 2 different treatment groups
This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.
"The development of CVD is an interaction of the individual's profile of genetic vulnerability and exposure to environmental factors, which may act synergistically or operate independently." - Anonymous Online Contributor
"It is important for patients, physicians and policy makers to become acquainted with the latest research in cardiovascular diseases. The latest scientific evidence on cardiovascular diseases from scientific research supports evidence-based interventions." - Anonymous Online Contributor
"For general population with no previous history of CVD the leading CV medications/interventions are aspirin, and statins while those without known CVD are more inclined toward anti-platelet medications. Also there is a high prevalence of aspirin and CV-directed therapies in patients with CVD." - Anonymous Online Contributor
"Some early signs of cardiovascular disease include the abnormal heart beat, dizziness or shortness of breath. Other early signs of heart disease include pain in the chest or chest pain with exertion.\n" - Anonymous Online Contributor
"Cardiovascular Disease Prevention programmes aim at reducing the risk of major cardiovascular illnesses and total morbidity and mortality in the population. By identifying those populations and individuals at higher risk, cardiovascular disease prevention programmes should focus on the most important risk factors." - Anonymous Online Contributor
"The current study indicates that cardiovascular diseases may be an aggravating factor in women with the metabolic syndrome. It is recommended that healthcare providers take note of the cardiovascular risk factors in women with metabolic syndrome in order to enhance their cardiovascular risk reduction strategies. More research is needed, especially regarding associations with metabolic syndrome and cardiovascular disease in women." - Anonymous Online Contributor
"This is the first meta-analysis to provide evidence that can heal chronic diseases of the cardiovascular system. While a full cure cannot be achieved, it seems that some chronic diseases can be controlled. In a recent study, findings could have significant impact on the design and implementation of future clinical trials." - Anonymous Online Contributor
"There appears to be a trend that is associated with more advanced disease in people with a history of CVD. For example, men tend to have a higher risk of CVD even if they are younger and women have a lower risk. Although this trend is most pronounced early in life, we are all at risk for cardiovascular disease at any age." - Anonymous Online Contributor
"It is clear from this research that treatment and prognosis for patients with [multiple myeloma](https://www.withpower.com/clinical-trials/multiple-myeloma) are currently very different. Although the prognosis is better for patients diagnosed when the disease is minimal, treatment and options remain very limited and, even, are often unsuccessful. This has created a need for clinical research to investigate the causes and effects of myeloma. Future research should be directed at improving outcomes from myeloma." - Anonymous Online Contributor
"Patients undergoing therapy can experience some common side effects that are dose dependent and are related directly to the treatment itself. [Fever, loss of appetite, diarrhea, joint pain, chest discomfort and/or shortness of breath are a few of the common side effects of treatment.] These common side effects can be mitigated by seeking medical advice immediately after starting therapy. You can find side effects by using Power to search by treatment and side effects." - Anonymous Online Contributor
"A number of additional relevant investigations have been performed with the aim of detecting potential benefits such as reducing the risk of developing future cardiovascular disease. Although many of these studies have been conducted after the initial trial was concluded, the results of their primary investigations still need to be interpreted and assessed for their clinical relevance." - Anonymous Online Contributor
"Genetic counseling is a crucial part of medical genetics and family health. The incidence of common CVDs and their genetic loci may vary, depending on ethnicity, gender and geographic distribution. This is one of the first studies to explore the association of CVDs and genetic loci." - Anonymous Online Contributor